Universe Pharmaceuticals INC (UPC)
NASDAQ: UPC · Real-Time Price · USD
3.790
-0.300 (-7.33%)
At close: Jul 23, 2026, 4:00 PM EDT
3.510
-0.280 (-7.39%)
After-hours: Jul 23, 2026, 4:57 PM EDT

UPC Ratios and Metrics

Millions USD. Fiscal year is Oct - Sep.
Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jul '26 Sep '25 Sep '24 Sep '23 Sep '22 Sep '21
22631254
Market Cap Growth
25.91%-62.31%82.28%-71.97%-77.13%-
Enterprise Value
-21.72-21.97-15.233.64-2.6436.25
Last Close Price
3.794.20146.40570.002034.008892.00
PE Ratio
-----4.14
PS Ratio
0.150.130.270.110.311.12
PB Ratio
0.040.040.140.120.260.91
P/TBV Ratio
0.030.030.050.120.270.80
P/FCF Ratio
---3.21--
P/OCF Ratio
---3.08--
EV/Sales Ratio
--1.23-0.660.11-0.070.76
EV/EBITDA Ratio
-9.162.02-0.412.58
EV/EBIT Ratio
-7.531.90-0.382.67
EV/FCF Ratio
-4.131.563.391.89-
Debt / Equity Ratio
0.130.130.180.200.080.07
Debt / EBITDA Ratio
-----0.31
Debt / FCF Ratio
---5.11--
Net Debt / Equity Ratio
-0.43-0.43-0.470.01-0.32-0.30
Net Debt / EBITDA Ratio
10.1510.152.85-0.062.30-1.24
Net Debt / FCF Ratio
4.584.582.210.1810.701.12
Asset Turnover
0.240.260.420.640.620.97
Inventory Turnover
4.015.886.677.937.8210.37
Quick Ratio
3.713.712.37140.802.603.36
Current Ratio
4.074.072.541.843.174.50
Return on Equity (ROE)
-6.60%-7.23%-20.45%-5.57%-11.92%40.22%
Return on Assets (ROA)
-3.89%-4.25%-13.53%-3.75%-9.58%32.21%
Return on Invested Capital (ROIC)
-9.17%-10.45%-28.45%-6.37%-17.03%58.09%
Return on Capital Employed (ROCE)
-5.14%-5.62%-21.21%-10.66%-13.32%34.09%
Earnings Yield
-----24.16%
FCF Yield
---31.14%--
Buyback Yield / Dilution
-3174.93%-3174.94%-130.39%0.00%-14.60%-18.63%
Total Shareholder Return
-3174.93%-3174.94%-130.39%0.00%-14.60%-18.63%
SEC Filings: 10-K · 10-Q